Open Access
188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells
Тип публикации: Journal Article
Дата публикации: 2022-05-01
scimago Q3
wos Q4
БС3
SJR: 0.521
CiteScore: 3.5
Impact factor: 1.7
ISSN: 22285806, 22285814
PubMed ID:
35717568
Краткое описание
Objective
Epigenetic alterations, including any change in DNA methylation pattern, could be the missing link of understanding radiation-induced genomic instability. Dapper, Dishevelled-associated antagonist of β-catenin homolog 2 (DACT2) is a tumor suppressor gene regulating Wnt/β-catenin. In hepatocellular carcinoma (HCC), DACT2 is hypermethylated, while methylation status of its promoter regulates the corresponding expression. Radionuclides have been used to reduce proliferation and induce apoptosis in cancerous cells. Epigenetic impact of radionuclides as therapeutic agents for treatment of HCC is still unknown. The aim of this study was to evaluate epigenetic impact of 188Rhenium perrhenate (188ReO4) on HCC cells.
Materials and Methods
In this in vitro experimental study, HepG2 and Huh7 cells were treated with 188ReO4, receiving 55 and 73 Mega Becquerel (MBq) exposures, respectively. For cell viability measurement, live/dead staining was carried out 18, 24, and 48 hours post-exposure. mRNA expression level of β-Catenin, Wnt1, DNMT1, DACT2 and WIF- 1 genes were quantified by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Then, possible regulatory impact of DACT2 upregulation was investigated through evaluating methylation-specific PCR (MS-PCR).
Results
Results showed that viability of both cells was reduced after treatment with 188ReO4 at three time points postexposure compared to the control groups. The qRT-PCR results showed that DACT2 mRNA level was significantly increased at 24, and 48 hours post-exposure in HepG2 cells compared to the control group, while, no significant change was observed in Huh7 cells. Methylation pattern of DACT2 promoter remained unchanged in HepG2 and Huh7 cells.
Conclusion
Treatment with 188ReO4 reduced viability of HepG2 and Huh7 cells. Although DACT2 expression was increased after 188ReO4 exposure in HepG2 cells, methylation pattern of its promoter remained unchanged. This study assessed impacts of the 188ReO4 β-irradiation on expression and induction of DACT2 epigenetic aberrations as well as the correlation of this agent with viability of cells.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
0
Всего цитирований:
0
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Asadian S. 188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells // Cell Journal. 2022. Vol. 24. No. 5. pp. 215-221.
ГОСТ со всеми авторами (до 50)
Скопировать
Asadian S. 188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells // Cell Journal. 2022. Vol. 24. No. 5. pp. 215-221.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.22074/cellj.2022.7894
UR - https://doi.org/10.22074/cellj.2022.7894
TI - 188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells
T2 - Cell Journal
AU - Asadian, S
PY - 2022
DA - 2022/05/01
PB - Royan Institute
SP - 215-221
IS - 5
VL - 24
PMID - 35717568
SN - 2228-5806
SN - 2228-5814
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2022_Asadian,
author = {S Asadian},
title = {188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells},
journal = {Cell Journal},
year = {2022},
volume = {24},
publisher = {Royan Institute},
month = {may},
url = {https://doi.org/10.22074/cellj.2022.7894},
number = {5},
pages = {215--221},
doi = {10.22074/cellj.2022.7894}
}
Цитировать
MLA
Скопировать
Asadian, S.. “188Rhenium Treatment Induces DACT2 Expression in Hepatocellular Carcinoma Cells.” Cell Journal, vol. 24, no. 5, May. 2022, pp. 215-221. https://doi.org/10.22074/cellj.2022.7894.